These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26587876)

  • 1. Clinical predictors of silent but substantial liver fibrosis in primary Sjogren's syndrome.
    Lee SW; Kim BK; Park JY; Kim do Y; Ahn SH; Song J; Park YB; Lee SK; Han KH; Kim SU
    Mod Rheumatol; 2016 Jul; 26(4):576-82. PubMed ID: 26587876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and clinical impact of fibromyalgia in patients with primary Sjögren's syndrome.
    Choi BY; Oh HJ; Lee YJ; Song YW
    Clin Exp Rheumatol; 2016; 34(2 Suppl 96):S9-13. PubMed ID: 26315451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elastographic ultrasound: an additional image tool in Sjögren's syndrome.
    Kimura-Hayama E; Criales-Vera S; Azpeitia-Espinosa L; Pacheco-Molina C; Reyes E; Lima G; Hernandez-Ramirez D; Llorente L; Hernandez-Molina G
    Int J Rheum Dis; 2018 Jun; 21(6):1293-1300. PubMed ID: 29624878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
    Seror R; Bootsma H; Saraux A; Bowman SJ; Theander E; Brun JG; Baron G; Le Guern V; Devauchelle-Pensec V; Ramos-Casals M; Valim V; Dörner T; Tzioufas A; Gottenberg JE; Solans Laqué R; Mandl T; Hachulla E; Sivils KL; Ng WF; Fauchais AL; Bombardieri S; Priori R; Bartoloni E; Goeb V; Praprotnik S; Sumida T; Nishiyama S; Caporali R; Kruize AA; Vollenweider C; Ravaud P; Meiners P; Brito-Zerón P; Vitali C; Mariette X;
    Ann Rheum Dis; 2016 Feb; 75(2):382-9. PubMed ID: 25480887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of sleep quality on clinical features of primary Sjögren's syndrome.
    Chung SW; Hur J; Ha YJ; Kang EH; Hyon JY; Lee HJ; Song YW; Lee YJ
    Korean J Intern Med; 2019 Sep; 34(5):1154-1164. PubMed ID: 29458245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease duration and Medsger's severity score are associated with significant liver fibrosis in patients with systemic sclerosis.
    Lee SW; Kim BK; Park JY; Kim DY; Ahn SH; Song JJ; Park YB; Lee SK; Han KH; Kim SU
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S68-74. PubMed ID: 26243041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
    Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline disease activity influences subsequent achievement of patient acceptable symptom state in Sjögren's syndrome.
    Park EH; Ha YJ; Kang EH; Song YW; Scofield RH; Lee YJ
    Rheumatology (Oxford); 2021 Jun; 60(6):2714-2724. PubMed ID: 33188390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).
    Seror R; Theander E; Brun JG; Ramos-Casals M; Valim V; Dörner T; Bootsma H; Tzioufas A; Solans-Laqué R; Mandl T; Gottenberg JE; Hachulla E; Sivils KL; Ng WF; Fauchais AL; Bombardieri S; Valesini G; Bartoloni E; Saraux A; Tomsic M; Sumida T; Nishiyama S; Caporali R; Kruize AA; Vollenweider C; Ravaud P; Vitali C; Mariette X; Bowman SJ;
    Ann Rheum Dis; 2015 May; 74(5):859-66. PubMed ID: 24442883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab.
    Meiners PM; Arends S; Brouwer E; Spijkervet FK; Vissink A; Bootsma H
    Ann Rheum Dis; 2012 Aug; 71(8):1297-302. PubMed ID: 22258489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EULAR Sjogren's syndrome patient reported index as an independent determinant of health-related quality of life in primary Sjogren's syndrome patients: in comparison with non-Sjogren's sicca patients.
    Cho HJ; Yoo JJ; Yun CY; Kang EH; Lee HJ; Hyon JY; Song YW; Lee YJ
    Rheumatology (Oxford); 2013 Dec; 52(12):2208-17. PubMed ID: 24023247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Fibrosis in Primary Sjögren's Syndrome.
    Androutsakos T; Voulgaris TA; Bakasis AD; Koutsompina ML; Chatzis L; Argyropoulou OD; Pezoulas V; Fotiadis DI; Papatheodoridis G; Tzioufas AG; Goules AV
    Front Immunol; 2022; 13():889021. PubMed ID: 35784296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.
    Cornec D; Devauchelle-Pensec V; Mariette X; Jousse-Joulin S; Berthelot JM; Perdriger A; Puéchal X; Le Guern V; Sibilia J; Gottenberg JE; Chiche L; Hachulla E; Yves Hatron P; Goeb V; Hayem G; Morel J; Zarnitsky C; Dubost JJ; Saliou P; Pers JO; Seror R; Saraux A
    Arthritis Care Res (Hoboken); 2017 Apr; 69(4):528-535. PubMed ID: 27390310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EULAR Sjögren's Syndrome Patient-Reported Index is an independent determinant of health-related utility values of Korean patients with primary Sjögren's syndrome.
    Lee J; Koh JH; Kwok SK; Park SH
    Clin Exp Rheumatol; 2016; 34(4):663-7. PubMed ID: 27050672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
    Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
    Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of systemic activity of pediatric primary Sjögren's syndrome by EULAR Sjögren's syndrome disease activity index (ESSDAI).
    Kobayashi I; Okura Y; Ueki M; Tozawa Y; Takezaki S; Yamada M; Ariga T
    Mod Rheumatol; 2019 Jan; 29(1):130-133. PubMed ID: 29529894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Lee HW; Kim BK; Kim SU; Park JY; Kim DY; Ahn SH; Kim KJ; Han KH
    Dig Dis Sci; 2017 Aug; 62(8):2150-2158. PubMed ID: 28523578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of primary Sjögren's syndrome on female sexual function.
    van Nimwegen JF; Arends S; van Zuiden GS; Vissink A; Kroese FG; Bootsma H
    Rheumatology (Oxford); 2015 Jul; 54(7):1286-93. PubMed ID: 25652072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain, xerostomia, and younger age are major determinants of fatigue in Korean patients with primary Sjögren's syndrome: a cohort study.
    Koh JH; Kwok SK; Lee J; Son CN; Kim JM; Kim HO; Park SH; Sung YK; Choe JY; Lee SS; Park SH
    Scand J Rheumatol; 2017 Jan; 46(1):49-55. PubMed ID: 27098775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?
    Lendrem D; Mitchell S; McMeekin P; Gompels L; Hackett K; Bowman S; Price E; Pease CT; Emery P; Andrews J; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Ng WF;
    Rheumatology (Oxford); 2015 Apr; 54(4):655-9. PubMed ID: 25240612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.